M
Marcel H.A.M. Fens
Researcher at Utrecht University
Publications - 59
Citations - 3022
Marcel H.A.M. Fens is an academic researcher from Utrecht University. The author has contributed to research in topics: Drug delivery & Medicine. The author has an hindex of 23, co-authored 49 publications receiving 2431 citations. Previous affiliations of Marcel H.A.M. Fens include University Medical Center Utrecht & Children's Hospital Oakland Research Institute.
Papers
More filters
Journal ArticleDOI
PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
Sander A.A. Kooijmans,Lies A. L. Fliervoet,R. van der Meel,Marcel H.A.M. Fens,Harry F. G. Heijnen,P. M. P. Van Bergen En Henegouwen,Pieter Vader,Raymond M. Schiffelers +7 more
TL;DR: Post-insertion is proposed as a novel technique to confer targeting capacity to isolated EVs, circumventing the requirement to modify EV-secreting cells, and equips EVs with improved cell specificity and prolonged circulation times, potentially increasing EV accumulation in targeted tissues and improving cargo delivery.
Journal ArticleDOI
Extracellular vesicles as drug delivery systems: lessons from the liposome field.
Roy van der Meel,Marcel H.A.M. Fens,Pieter Vader,Wouter W. van Solinge,Omolola Eniola-Adefeso,Raymond M. Schiffelers +5 more
TL;DR: By applying beneficial features of EVs to liposomes and vice versa, improved drug carriers can be developed which will advance the field of nanomedicines and ultimately improve patient outcomes.
Journal ArticleDOI
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
Raymond M. Schiffelers,Gerben A. Koning,Timo L.M. ten Hagen,Marcel H.A.M. Fens,Astrid J. Schraa,Adrienne P.C.A. Janssen,Robbert J. Kok,Grietje Molema,Gert Storm +8 more
TL;DR: Coupling of RGD to LCL redirected these liposomes to angiogenic endothelial cells in vitro and in vivo, and showed superior efficacy over non-targeted LCL in inhibiting C26 doxorubicin-insensitive tumor outgrowth.
Journal ArticleDOI
Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Osamu Soga,Cornelus F. van Nostrum,Marcel H.A.M. Fens,Cristianne J.F. Rijcken,Raymond M. Schiffelers,Gert Storm,Wim E. Hennink +6 more
TL;DR: In this paper, the preparation, release and in vitro cytotoxicity of a novel polymeric micellar formulation of paclitaxel (PTX) were investigated, where the loading was done by simply mixing of a small volume of a concentrated PTX solution in ethanol and an aqueous polymer solution and subsequent heating of the resulting solution above the critical micelle temperature of the polymer.
Journal ArticleDOI
Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π–Π Stacking Stabilized Polymeric Micelles
Yang Shi,Roy van der Meel,Benjamin Theek,Erik Oude Blenke,Ebel H. E. Pieters,Marcel H.A.M. Fens,Josef Ehling,Raymond M. Schiffelers,Gert Storm,Gert Storm,Cornelus F. van Nostrum,Twan Lammers,Twan Lammers,Twan Lammers,Wim E. Hennink +14 more
TL;DR: PTX-loaded micelles are developed which are stable without chemical cross-linking and covalent drug attachment, and are characterized by excellent loading capacity and strong drug retention, attributed to π-π stacking interaction between PTX and the aromatic groups of the polymer chains in the micellar core.